| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/03/2003 | CN1440412A Thienopyrrolidinones |
| 09/03/2003 | CN1440411A Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 09/03/2003 | CN1440410A Diazabicyclic central nervous systems active agents |
| 09/03/2003 | CN1440409A Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 09/03/2003 | CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/03/2003 | CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders |
| 09/03/2003 | CN1440401A Amino substituted dibenzothiophene derivatives for treatmnt of disorders mediated by NP Y5 receptor |
| 09/03/2003 | CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides |
| 09/03/2003 | CN1440399A Coumarin derivatives with COMT inhibiting activity |
| 09/03/2003 | CN1440398A Substituted phthalides as anti-convulsive drugs |
| 09/03/2003 | CN1440383A PPARγ调制剂 PPARγ modulators |
| 09/03/2003 | CN1440290A 7-Hydroxyepiandrosterone having neuroprotective activity |
| 09/03/2003 | CN1440287A Method of treating peripheral vascular diseases, peripheral neuropathies, and automatic neuropathies |
| 09/03/2003 | CN1440286A Therapeutic or preventive medicines for mood disorders or anxiety disorders |
| 09/03/2003 | CN1439673A High friction coefficient rubber composite brake shoes |
| 09/03/2003 | CN1439632A Sulfolipid compound with neural nourishing function and synthetic method and application thereof |
| 09/03/2003 | CN1439411A Chinese medicine against drug dependence |
| 09/03/2003 | CN1439409A Chinese and chemical medicine composition for treatment of alcoholism and preparation thereof |
| 09/03/2003 | CN1439394A Chinese medicine formula for metal disease |
| 09/03/2003 | CN1439388A Chinese patent drug for treating drug dependence |
| 09/03/2003 | CN1439375A 脱氢表雄酮的治疗用途和传送系统 DHEA therapeutic uses and delivery systems |
| 09/03/2003 | CN1120167C Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles having an affinity for alpha and/or 5HTIA receptors |
| 09/03/2003 | CN1120154C 4-hydroxy-piperdine derivatives |
| 09/03/2003 | CN1120008C Method for preparing Chinese medicine for curing epilepsy |
| 09/03/2003 | CN1120006C Chinese medicine for curing psychosis and its preparing method |
| 09/02/2003 | US6614719 Ultrasonic doppler effect speed measurement |
| 09/02/2003 | US6613920 25-(5-propylimidazol-2-yl)-26,27-cyclo-9, 10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; antagonizes the action of calcitriol in HL 60 cells; hyperprolifierative diseases of the skin, tumor diseases and precancerous stages |
| 09/02/2003 | US6613917 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/02/2003 | US6613913 Intermediate for antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1, 6,9-trioxa-3-aza-cyclopenta [a]naphthalene |
| 09/02/2003 | US6613911 Reaction of haloarylacetic acids or esters with olefins to give vinylarylacetic acids or esters, oxidation with an oxidizing reagent gives formylarylacetic acids or esters |
| 09/02/2003 | US6613905 Chemokine receptor antagonists and methods of use therefor |
| 09/02/2003 | US6613901 For therapy and prophylaxis of neuropsychochological disorders such as schizophrenia and other central nervous system diseases |
| 09/02/2003 | US6613892 Continuously expressing an inserted heterologous gene while remaining latent |
| 09/02/2003 | US6613874 Melanocortin receptor ligands |
| 09/02/2003 | US6613807 Linking low molecular weight drugs containing a carboxylic acid group and an amine, thiol, alcohol or phenol, which is released when hydrolysis occurs |
| 09/02/2003 | US6613803 Treating, preventing or ameliorating pain |
| 09/02/2003 | US6613802 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/02/2003 | US6613801 Method for the synthesis of compounds of formula I and their uses thereof |
| 09/02/2003 | US6613796 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 09/02/2003 | US6613790 Prodrugs of COX-2 inhibitors |
| 09/02/2003 | US6613781 Potential use in the treatment of a variety of central nervous system disorders such as anxiety, depression, epilepsy, obsessive-compulsive disorders, migraine, congnitive disorders, sleep disorders and schizophrenia |
| 09/02/2003 | US6613779 Use of R(+) -α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idinemethanol for the treatment of sleep disorders |
| 09/02/2003 | US6613778 Imidazopyridine derivatives as phosphodiesterase VII inhibitors |
| 09/02/2003 | US6613777 CRF antagonistic pyrazolo[4,3-b]pyridines |
| 09/02/2003 | US6613776 Protein serine/threonine kinase inhibitors used for treating diseases such as cancer, diabetes and Alzheimer's disease |
| 09/02/2003 | US6613772 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 09/02/2003 | US6613770 Quinoline derivatives as NK-2 and NK-3 receptor ligands |
| 09/02/2003 | US6613766 Compounds such as 3-(5-methylisoxazol-3-yl)-5-(2-pyridyl-methyloxy)-1,2,3a,4,6 -pentaazacyclopenta(a)naphthalene, having high receptivity for the inhibitory neurotransmitter, gamma-aminobutyric acid (GABA); learning enhancement |
| 09/02/2003 | US6613765 Use of NK-1 receptor antagonists for treating major depressive disorders |
| 09/02/2003 | US6613763 Use of molindone to treat oppositional defiant disorder and conduct disorder |
| 09/02/2003 | US6613760 Indole derivatives and their use as MCP-1 receptor antagonists |
| 09/02/2003 | US6613572 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 09/02/2003 | US6613367 Complete nutrition of infants products are characterized by the type and amount of protein and carbohydrate and the increased levels of folic acid, vitamin B6 and vitamin B12 or their functional equivalents. These products improve feelings |
| 09/02/2003 | US6613322 Administering enzyme inhibitors |
| 09/02/2003 | US6613308 Administering to the respiratory tract a drug at a dose which is at least about two-fold less than the dose required by oral administration. |
| 09/02/2003 | CA2151543C Immunogens for the production of cocaine-hydrolyzing catalytic antibodies |
| 08/28/2003 | WO2003070970A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070969A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070968A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070965A2 The eaat2 promoter and uses thereof |
| 08/28/2003 | WO2003070918A2 Rna interference by modified short interfering nucleic acid |
| 08/28/2003 | WO2003070914A2 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070911A2 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/28/2003 | WO2003070903A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070902A2 Receptors and membrane-associated proteins |
| 08/28/2003 | WO2003070895A2 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070886A2 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid |
| 08/28/2003 | WO2003070760A2 Anti-amyloid beta antibodies and their use |
| 08/28/2003 | WO2003070755A2 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier |
| 08/28/2003 | WO2003070753A1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096 |
| 08/28/2003 | WO2003070744A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070739A1 Partial and full agonists of a1 adenosine receptors |
| 08/28/2003 | WO2003070738A2 Topiramate salts and compositions comprising and methods of making and using the same |
| 08/28/2003 | WO2003070732A1 Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease |
| 08/28/2003 | WO2003070731A2 Azabicyclic compounds for the treatment of disease |
| 08/28/2003 | WO2003070730A1 Pyrrolopyrimidine derivative |
| 08/28/2003 | WO2003070729A1 Pyrrolopyrimidine derivatives |
| 08/28/2003 | WO2003070728A2 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders |
| 08/28/2003 | WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer |
| 08/28/2003 | WO2003070726A1 Pyranones useful as atm inhibitors |
| 08/28/2003 | WO2003070723A1 5-heteroaryl substituted indoles |
| 08/28/2003 | WO2003070711A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 08/28/2003 | WO2003070709A1 Novel phenylalanine derivative |
| 08/28/2003 | WO2003070707A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/28/2003 | WO2003070706A1 Tricyclic pyrazole derivatives for the treatment of inflammation |
| 08/28/2003 | WO2003070691A1 N-hydroxycarboxamide derivative |
| 08/28/2003 | WO2003070686A1 Substituted phenylalkanoic acid derivative and use thereof |
| 08/28/2003 | WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 08/28/2003 | WO2003070304A1 Dose dispensing system and apparatus |
| 08/28/2003 | WO2003070280A2 Absorption enhancing agent |
| 08/28/2003 | WO2003070278A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors |
| 08/28/2003 | WO2003070273A1 A bioadhesive agent |
| 08/28/2003 | WO2003070269A1 Treatment for diseases of the eye, inner ear and central nervous system |
| 08/28/2003 | WO2003070251A1 Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 08/28/2003 | WO2003070246A1 Controlled synthesis of ziprasidone and compositions thereof |
| 08/28/2003 | WO2003070245A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| 08/28/2003 | WO2003070244A1 Antagonist of melanin concentrating hormone and their uses |
| 08/28/2003 | WO2003070242A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases |
| 08/28/2003 | WO2003070237A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2 |
| 08/28/2003 | WO2003070236A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |